Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
Tissue preparation for drug analysis, as denoted by CPT® Code 80103, involves the meticulous process of preparing biological samples such as hair, nails, stool, or other body tissues or fluids. This preparation is essential for laboratory analysis aimed at detecting the presence of drugs or chemicals within the sample. The primary objective of this procedure is to evaluate an individual's exposure to one or more substances, which can serve various purposes including investigative assessments or ongoing monitoring of substance use. The preparation phase is critical as it ensures that the sample is adequately processed to facilitate accurate testing for the specific drug or chemical being screened. This step is foundational in the overall drug analysis process, as it directly impacts the reliability and validity of the subsequent laboratory results.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure of tissue preparation for drug analysis is indicated in various scenarios where there is a need to assess exposure to drugs or chemicals. The following conditions may warrant this procedure:
The procedure for tissue preparation for drug analysis involves several critical steps to ensure that the biological sample is adequately prepared for testing. Each step is essential for achieving accurate and reliable results.
After the tissue preparation for drug analysis is completed, the sample is ready for laboratory testing. Post-procedure care primarily involves ensuring that the prepared samples are stored correctly to maintain their integrity until testing occurs. It is also important to document the preparation process and any relevant details about the sample collection and handling. The expected recovery from this procedure is immediate, as it is primarily a preparatory step rather than an invasive procedure. Additional considerations may include following up on the results of the drug analysis and ensuring that any necessary actions are taken based on the findings.
| Short Descr | DRUG ANALYSIS TISSUE PREP | Medium Descr | TISSUE PREPARATION DRUG ANALYSIS | Long Descr | Tissue preparation for drug analysis | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 9 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Items and Services Packaged into APC Rates | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | Not applicable/unspecified. | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
Get instant expert-level medical coding assistance.